0.05Open0.05Pre Close0 Volume11 Open Interest2.50Strike Price0.00Turnover8015.21%IV58.12%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0327Delta0.0231Gamma117.00Leverage Ratio-6.6970Theta0.0000Rho-3.83Eff Leverage0.0000Vega
Applied Therapeutics Stock Discussion
$Applied Therapeutics (APLT.US)$
The biopharmaceutical company said Thursday that the Food and Drug Administration now has a target action date of Nov. 28 for its application, compared with the previous date of Aug. 28.
The company's application is for govorestat in the treatment of Galactosemia, a rare genetic condition that makes patients unable to metab...
In a significant development for the healthcare sector and investors worldwide, Applied Therapeutics Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, has announced the Food and Drug Administration's acceptance and priority review of t...
No comment yet